Global healthcare company Abbott announced the launch of its latest generation XIENCE Sierra everolimus-eluting coronary stent system in India. This launch comes after the stent system received regulatory approval from India's Central Drugs Standard Control Organisation (CDSCO) in February 2023. The XIENCE Sierra is part of Abbott's family of drug-eluting...